Skip to main content

Voxelotor Tablet Shortage

Last Updated: September 27, 2024
Status: Discontinued

To Be Discontinued:

Oxbryta, Tablet, 300 mg (Pfizer Inc.)

NDC Code: 72786-102-02
Status: To Be Discontinued
Date of update: September 27, 2024
Update type: New
Therapeutic category: Hematology
Date discontinued: September 27, 2024
Initial posting date: September 27, 2024
Contact info: 800-533-4535

Oxbryta, Tablet, 300 mg (Pfizer Inc.)

NDC Code: 72786-102-03
Status: To Be Discontinued
Date of update: September 27, 2024
Update type: New
Therapeutic category: Hematology
Date discontinued: September 27, 2024
Initial posting date: September 27, 2024
Contact info: 800-533-4535

Oxbryta, Tablet, 300 mg (Pfizer Inc.)

NDC Code: 72786-111-03
Status: To Be Discontinued
Date of update: September 27, 2024
Update type: New
Therapeutic category: Hematology
Date discontinued: September 27, 2024
Initial posting date: September 27, 2024
Contact info: 800-533-4535

Oxbryta, Tablet, 300 mg (Pfizer Inc.)

NDC Code: 72786-111-02
Status: To Be Discontinued
Date of update: September 27, 2024
Update type: New
Therapeutic category: Hematology
Date discontinued: September 27, 2024
Initial posting date: September 27, 2024
Contact info: 800-533-4535

Oxbryta, Tablet, 500 mg (Pfizer Inc.)

NDC Code: 72786-101-01
Status: To Be Discontinued
Date of update: September 27, 2024
Update type: New
Therapeutic category: Hematology
Date discontinued: September 27, 2024
Initial posting date: September 27, 2024
Contact info: 800-533-4535

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer